1. Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye
- Author
-
Tanzina Chowdhury, Kenneth C Johnson, Andrew W. Stacey, Catriona Duncan, Ido Didi Fabian, Mandeep S. Sagoo, and M. Ashwin Reddy
- Subjects
Male ,Under anaesthesia ,medicine.medical_specialty ,Time Factors ,Multivariate analysis ,Retinal Neoplasms ,medicine.medical_treatment ,Enucleation ,Eye Enucleation ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Older patients ,Humans ,Medicine ,Retrospective Studies ,Chemotherapy ,business.industry ,Retinoblastoma ,Significant difference ,Infant ,medicine.disease ,Combined Modality Therapy ,Sensory Systems ,Surgery ,Ophthalmology ,Child, Preschool ,Cohort ,030221 ophthalmology & optometry ,Female ,business ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
BackgroundChemotherapy is increasingly used as primary treatment for group D retinoblastoma, whereas primary enucleation is considered to have a diminishing role. This study aimed to compare the management course, including number of examinations under anaesthesia (EUAs), of group D patients treated by enucleation versus chemotherapy.MethodsA retrospective analysis of 92 group D patients, of which 40 (37 unilateral) underwent primary enucleation and 52 (17 unilateral) were treated with intravenous chemotherapy. Number of EUAs was compared between the treatment groups with respect to the whole cohort, using univariate and multivariate analysis, and to unilateral cases only.ResultsPatients were followed up for a median of 61 months (mean: 66, range: 14–156), in which time primary enucleated patients had on average seven EUAs and chemotherapy-treated patients 21 EUAs (pConclusionGroup D patients’ families should be counselled regarding the significant difference in number of EUAs following primary enucleation versus chemotherapy when deciding on a treatment strategy. In this regard, primary enucleation would be most beneficial for older patients with unilateral disease.
- Published
- 2017